Antoine Soetewey

Dr. Antoine Soetewey

UCLouvain, Louvain-la-Neuve, Wallonia, Belgium
orcid
Postdoctoral researcher in data science and statistics

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in European Actuarial Journal
Verified
Journal Article
Closed access
PDF file
Antoine SoeteweyAntoine Soetewey
Antoine Soetewey
CLCatherine Legrand
Catherine Legrand
MDMichel Denuit
Michel Denuit
GSGeert Silversmit
Geert Silversmit

2 May 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
HTHieu Cong Truong
Hieu Cong Truong
TPThanh Van Phan
Thanh Van Phan
HNHung Thanh Nguyen
Hung Thanh Nguyen
KTKhanh Huu Truong
Khanh Huu Truong
VDViet Chau Do
Viet Chau Do
NSNiko Speybroeck
Niko Speybroeck
Bacterial meningitis is a significant public health concern worldwide, with Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis being the most common causative pathogens. A retrospective hospital-based surveillance study in southern Vietnam from 2012 to 2021 identified 158 confirmed bacterial meningitis cases, with S. pneumoniae being the primary cause of bacterial meningitis in children under five years of age. The disease was more prevalent in children aged 1-11 months during the dry season, with a case fatality rate of 8.2%. The most common pneumococcal serotypes were 6A/B, 19F, 14, and 23F. After the introduction of the 10-valent pneumococcal vaccine at private healthcare services, the study found a decrease in the proportion of pneumococcal meningitis cases caused by vaccine serotypes. These results suggest the importance of ongoing monitoring and implementing pneumococcal conjugate vaccines in the Expanded Program on Immunization in Vietnam. Policymakers and healthcare professionals can use these valuable insights to effectively prevent and control the disease.

22 November 2020 in European Actuarial Journal
Verified
Journal Article
Closed access
PDF file
Antoine SoeteweyAntoine Soetewey
Antoine Soetewey
CLCatherine Legrand
Catherine Legrand
MDMichel Denuit
Michel Denuit
GSGeert Silversmit
Geert Silversmit

19 February 2024 in Research Square
Verified
Preprint
Open access
PDF file
Antoine SoeteweyAntoine Soetewey
Antoine Soetewey
CLCatherine Legrand
Catherine Legrand
MDMichel Denuit
Michel Denuit
GSGeert Silversmit
Geert Silversmit
Over the last decade, the number of years of life lost (YLL) became a popular tool in biostatistics and epidemiology to measure discrepancies in life expectancy or mortality between a cohort of patients and the general population. Its prominence in the literature is primarily due to its ease of interpretation and because information on the cause of death is not required. Moreover, multi-state models are a powerful statistical approach to study the evolution of individuals between several "states". Derived from data collected by the Belgian Cancer Registry, encompassing 161,007 cases of melanoma, thyroid, and female breast cancer, a three-state (healthy-cancer-death) illness-death model is used to illustrate how it can be applied to cancer registry data to estimate the incidence risk, and the number of years of life lost due to cancer at different ages at diagnosis and given that the patient survived some years after diagnosis. Results suggest that the probabilities of being diagnosed with cancer over the next 20 years for a healthy individual remain rather low for melanoma and thyroid cancers for both sexes, but considerably increases with age for female breast cancer. Results also suggest that, for female breast cancer, the number of years of life lost before the age of 70 years due to cancer is highest when diagnosed at young ages and then decreases with age at diagnosis, whereas for melanoma and thyroid cancers, it peaks when diagnosed at later ages (between 35 and 55 years depending on the cancer and sex). It also turns out that the number of years of life lost before the age of 70 due to cancer is larger for men than for women for both melanoma and thyroid cancers. Last, it is found that, for melanoma and thyroid cancer patients diagnosed between the age of 20 and 70 years, once they have survived their cancer for 10 years, the number of years of life lost before the age of 70 due to cancer remains below one year. This indicates that, up to the age of 70 years, these patients lose a limited number of years of life due to cancer compared to the general population.

15 December 2025 in SoftwareX
Verified
Journal Article
Open access
Antoine SoeteweyAntoine Soetewey
Antoine Soetewey
CHCédric Heuchenne
Cédric Heuchenne
ACArnaud Claes
Arnaud Claes
ADAntonin Descampe
Antonin Descampe

4 November 2024 in European Actuarial Journal
Verified
Journal Article
Closed access
PDF file
Antoine SoeteweyAntoine Soetewey
Antoine Soetewey
CLCatherine Legrand
Catherine Legrand
MDMichel Denuit
Michel Denuit
GSGeert Silversmit
Geert Silversmit